In the TME, increased CCR5 levels may be the result of high CCR5 expression on the tumor cell surface or the aggregation of CCR5+ cells, such as monocytes, lymphocytes, adipocytes, and mesenchymal stem cells (MSCs).161. The gene discussed is CCR5; the disease is neoplasm.